Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group (Q31962966)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

0 references

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Pierfranco Conte

18

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

K Aabo

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M Adams

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

P Adnitt

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

D S Alberts

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

A Athanazziou

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

V Barley

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

D R Bell

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

U Bianchi

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G Bolis

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M F Brady

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

H S Brodovsky

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

H Bruckner

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M Buyse

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

R Canetta

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

V Chylak

15

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

C J Cohen

16

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

N Colombo

17

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

D Crowther

19

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

J H Edmonson

20

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

C Gennatas

21

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

E Gilbey

22

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M Gore

23

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

D Guthrie

24

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

B Y Yeap

25

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

language of work or name

0 references

publication date

1 December 1998

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

78

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1479-1487

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063202

21 June 2018

Reporting, updating, and correcting systematic reviews of the effects of health care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063202

21 June 2018

Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063202

21 June 2018

Randomized trial of the addition of cis-platin (DDP) and/or BCG to cyclophosphamide (CTX) chemotherapy for ovarian carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063202

21 June 2018

Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063202

21 June 2018

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063202

21 June 2018

Cyclophosphamide-cisplatin versus cyclophosphamide-carboplatin in stage III-IV ovarian carcinoma: a comparison of equally myelosuppressive regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063202

21 June 2018

A comparison of the toxicity and efficacy of cisplatin and carboplatin in advanced ovarian cancer. The Swons Gynaecological Cancer Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063202

21 June 2018

A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063202

21 June 2018

Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063202

21 June 2018

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063202

21 June 2018

Tables of the number of patients required in clinical trials using the logrank test.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063202

31 October 2018

Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063202

31 October 2018

Cisplatin (P) versus cyclophosphamide, adriamycin and cisplatin (CAP) for stage III-IV epithelial ovarian carcinoma: a prospective randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/9836481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9836481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous treosulfan versus intravenous treosulfan plus cisplatinum in advanced ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9836481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparison of cyclophosphamide, doxorubicin and cisplatin (CAP) versus cyclophosphamide and doxorubicin (CA) for the treatment of advanced ovarian cancer (ADOVCA). A EORTC Gynecological Cancer Cooperative Group Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9836481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9836481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9836481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of the first randomized study of cisplatin versus carboplatin for advanced epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9836481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a Hellenic co-operative oncology group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9836481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced ovarian cancer: a prospective randomised trial of chlorambucil versus combined cyclophosphamide and cis-diamminedichloroplatinum

1 reference

https://pubmed.ncbi.nlm.nih.gov/9836481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

cis-Platinum, adriamycin, and hexamethylmelamine versus cyclophosphamide in advanced ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9836481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecologic Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9836481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective randomized trial comparing high-dose cisplatin with low-dose cisplatin and chlorambucil in advanced ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9836481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboplatin in combination therapy for ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9836481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Phase III study of carboplatin in ovarian cancer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/9836481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1998.710

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836481%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31962966&oldid=2175450753"